The randomized NLST had shown that three rounds of annual screening with low-dose CT reduced lung cancer mortality by 20% among current and former smokers as compared with the same number of annual ...

Introduction Inhaled gene therapy of muco-obstructive lung diseases requires a strategy to achieve therapeutically ... NK, GK, AL-B, SEB, SMR and JSS prepared the draft of the manuscript. NK, GK, JR, ...

Aim: Skeletal muscle convective and diffusive oxygen (O 2) transport are peripheral determinants of exercise capacity in both patients with chronic obstructive pulmonary disease (COPD) and chronic ...

Patients with obstructive pulmonary disease, restrictive pulmonary disease ... 30.5 (27.5; 35,5) years old vs. 36 (33; 39) years old, respectively (р=0.238). Most of the patients with a negative ...

Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death globally ... 10-year incidence was 52% higher than the QRISK3 score predicted (33.5% vs 22.1%). This difference was ...

As the disease worsens ... orthopnea may also be present. Pulmonary hypertension: High pressure in the blood vessels within the lungs that causes dyspnea, fatigue, and sometimes orthopnea and PND.

is widely accepted as a cornerstone of management for people with chronic obstructive pulmonary disease (COPD) and other chronic respiratory disorders.1 The most recent Cochrane review, comprising 65 ...

In a recent study, Mass General Brigham researchers demonstrated that through low-cost genetic samples that can be obtained from a cheek swab or blood test, they can improve identification of people ...

When you have moderate to severe disease, you and your doctor will work together to find the right therapy for you. Although there's no cure for COPD, devices like Inhaler, portable oxygen and ...

Image credit: Visual Vic/Getty Images. Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD) will hit 600 million by 2050. There are certain ...

Coming as climate change contributes to more extreme weather patterns, these text messages would be part of a nationwide forecasting tool for asthma and chronic obstructive pulmonary disease ...

The median length of survival for individuals with ILD who completed pulmonary rehabilitation was 6.1 years vs 4.7 years in the control group. Pulmonary rehabilitation (PR) may improve survival at 5 ...